The Lion Roars
This article was originally published in Start Up
Executive Summary
Johns Hopkins’ Lion Pharmaceuticals has an exclusive 90-day right of first negotiation on all small-molecule related technology from the university. Its goal is to create a mutual fund of drug targets with a portfolio of discovery technologies ready to develop them.